A Case of Antiphospholipid Syndrome Refractory to Secondary Anticoagulating Prophylaxis after Deep Vein Thrombosis-Pulmonary Embolism / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 274-278, 2014.
Article
em En
| WPRIM
| ID: wpr-159750
Biblioteca responsável:
WPRO
ABSTRACT
Antiphospholipid syndrome (APS) is an acquired systemic autoimmune disorder characterized by a combination of clinical criteria, including vascular thrombosis or pregnancy morbidity and elevated antiphospholipid antibody titers. It is one of the causes of deep vein thrombosis and pulmonary embolism that can be critical due to the mortality risk. Overall recurrence of thromboembolism is very low with adequate anticoagulation prophylaxis. The most effective treatment to prevent recurrent thrombosis is long-term anticoagulation. We report on a 17-year-old male with APS, who manifested blue toe syndrome, deep vein thrombosis, pulmonary thromboembolism, and cerebral infarction despite adequate long-term anticoagulation therapy.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Embolia Pulmonar
/
Recidiva
/
Tromboembolia
/
Trombose
/
Veias
/
Infarto Cerebral
/
Transtornos Cerebrovasculares
/
Mortalidade
/
Síndrome Antifosfolipídica
/
Anticorpos Antifosfolipídeos
Tipo de estudo:
Prognostic_studies
Limite:
Adolescent
/
Humans
/
Male
/
Pregnancy
Idioma:
En
Revista:
Tuberculosis and Respiratory Diseases
Ano de publicação:
2014
Tipo de documento:
Article